Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah I dumped to early today I wanted to vomit after I saw it move thought after half it would tank but oh no VOLUME short interest rocketed that bad boy past $2!!!!
This is about to pop to .50+
I know the feeling. GL
Nice job. I had 7k shares at 4 cents and sold way too early. Put it in here to early. Missed out on 14k. Damn it.
Just made $20,000 on FFIE sunk it all into JAGX LFG!!!!
All these stocks are getting squeeezed bad look at FFIE today!!!! WAIT UNTIL THE HERD COMES OUT WAY IT WILL SEND THIS WAAAAAY PAST $1!!!!!
Dan I had 7k shares of ffie at .04 the 8th of may. I wasn’t moving and jagx has a better looking outlook. But look at ffie now. 1.94 . Lost $13,000 by moving that money in a week. I like jagx potential a lot. I hope it happens sooner than later.
On the daily, the chart looks really good and (almost) ready to run. I think 0.25 was the bottom and it's only up from here.
Here we go come on need a PR and go break the .50 mark!!!
Which reasons do you have to assume it's bad? I can give you several reasons why I believe it will be good
Because if you do a little bit of DD on the company's history and its main ingredient used (crofelemer, already approved and used on humans -HIV- and dogs -cancer-, for the preventive treatment of diarrhea with no side effects for long term use), you would assume there's little chance for the study not being successful. But, of course, this is not 100% certain, so i recommend doing your own DD.
Some serious 'indecision' going on, with a touch of bias to the downside since the open...
So will whoever is absorbing whats being sold at 26 keep doing it, and for how long..
Hmmm
Or maybe it will be bad results. How you know it’s going to be good?!!!
100% Agreeee thank you so much! Best luck to you!!!
feel that posters pain...I wouldn't put anything past any ticker these days....It's just when someone speaks in absolutes ("for sure")on anything,It "definitely" lol gives me pause.
Next week, we are a week before ASCO congress. Napo pharmaceuticals is exhibiting there with a booth.
If they release the phase 3 results next week, NAPO is allowed to talk about it at the congress. They can not present an abstract (since they were too late for submission), but you are allowed to talk about it. Which would be VERY convenient on a congress like ASCO.
If you want to miss phase 3 data.. be our guest
My dog has diarrhea
Was todays activity a STOP LOSS ORDER take out??
that move that dropped the share price sharply down to 25 cents or so reminded me of a manuever by the market to clear out
STOP LOSS orders just sitting there. Volume has been way down, and I imagine there are shareholders who set up stop loss orders
to protect against a falling share price. The market makers can 'see' these orders, know how many shares are 'ripe' for the picking
and todays 'hit' has me thinking a lot of folks looked at their accounts and realized they no longer had their shares.
Sad part is, the share price is dropped thru the stop losses, bottoms out and then the trades are executed. And once they are cleaned out,
a bounce off the lows takes place.
Unfortunately, this is happening at a time when the momentum has been dampened and who knows when the next PR bump will occur and if
anyone is watching/waiting for it, with the ultimate question being, how big a bump might it get.
And someone just posted there could be shares available down in the 22 cents/sh range. If buyers are scarce?? its possible.. cause that move today
did not help things..
He should be able to get 22s tomorrow or Friday
REPLYING to: I want to buy it again so bad but worry about RS
They have until sometime in the 3rd qtr to be back above a $...
Unless they need to raise cash (r/s and then do an ATM or secondary)???
I think the bigger reason to be hesitant after todays action is that the share price might take a deeper leg down..
Its been on one heck of a run since 10 cents or less.. It could use a good consolidation/basing action.
Going to be interesting to see how serious the share holders are (how tight they hold their shares)
RS coming for sure they been dumping for a while and already been through 2 RS can’t take another one. Thank you and good luck!
They won't do r/s before announcing PIII results. And even after, it depends on the share price (above $1 or not) and their plans (they might still want to achieve $5+ with r/s), all before august (deadline for them to have the stock above $1 for ten consecutive trading days).
Personally, i'm more afraid of a sell the news type of event, rather than r/s.
I want to buy it again so bad but worry about RS
Bought a new round of shares on the current lows..
30 cents seems to be achievable based on recent activity. And if they can replicate that number, I will be happy with the purchase
Note: I don't discount the possibility that this could drop sub 26 cents if enough holders get restless and buyers don't step up.
Call it your standard share price CONSOLIDATION PHASE after a very nice sustained run up from sub 10 cents..
But if it does, can't do anything about it. Just have to hope the companys 'expectations' for something positive to come out of the PH 3
is fulfilled..
Disclaimer: own some, could have been more patient. And with time, will find out if I should have been (smile)
Good luck.
Was a thinking I was done trying to trade/flip shares.. But its chart is shaping up indicating
if there isn't any positive PR 'imminently'?? Some selling pressure is to be expected..
Got it trying to hold above its Moving Average line (around 27 cents), but if it sees 26 cents?? The MA
line will now be an overhead resistance it needs to claw back thru.. And a MA line that will
confirm rolling over lower and help 'push' the share price lower if buyers don't step up.
Disclaimer: own none, looking for another round for the 'imminent' PH 3 results... Going to be curious how high they
will be able to run up the share price on the news..
Tell folks management 'could' be your friend when things are going well for the company.
But when things are tough, its the company's 'survival' and 'best interests' that come first. And as a shareholder??
We should expect that or you may get 'nothing' instead of 'something'..
And its generally ugly for shareholders if you are owners of shares before something is being produced and revenues have
started flowing.. Ugly in terms of wall street demand for the shares may not be there, possible ATMs, secondaries and best of all??
Reverse splits..
And now it's time to finally reward shareholders !
Have been back in for a while. Just had to leave the board it was a bit nuts here for a while. Still not a fan of Lisa but I would say she has gotten the job done for the company but has had little or no regard for shareholders in the way she accomplished it
Yeah but they were too late to submit for ASCO. The titles of the abstract were allready released. Nothing about ONTARGET. So NO , they won't present at ASCO. Even not an abstract. Although I agree that they will release the results prior to the ASCO conference, to give NAPO something to talk about.
But don't pin May 23 in your agenda, because they won't be in it
P3 IMMINENT Then dollar land $$$
Thank you for the insight, i didn't know that. That would explain it...
And if, in their view, "imminent" doesn't mean "next 2-3 days from now", then i also think it will be closer to the ASCO conference, so end of may/1st days of june. Maybe even as early as 23th of may, because that's the date abstracts are presented/uploaded on the ASCO site, if i've read/understood this correctly.
If you read the filing you will see that the 16 million shares were set at a price of .18 which means they have a cap on how much they can be sold for... multiply 16 million time ,18 and what ever that figure is that is all that can be converted... that comes to $2,880,000 so if the sell at .26 or .50 or .99 once they have sold enough shares to rach $2.8 million they can not sell anymore... and Jaguar would prefer that all conversions take place prior to the Phase III so there is not a sell off that could drive the price back to a dollar or lower...
For me I think she said imminent because they are getting closer to the June conference and the seller will be done by then... Then when the conference is here they will release the Phase III results..... thats just my thinking but I have not seen anything that would tell me I am wrong.
Or maybe Gen Ilac preferred to do this before PIII, to not negatively impact the stock afterwards, since it needs to get to $1 till august, hopefully without r/s? idk... I wish Jaguar won't drag this for weeks, idk how much it can hold current levels without drops of positive news coming every 3 days or so.
Maybe 0.26 will be a strong support now and SMA200 (currently around 0.24) won't be touched again. Fingers crossed.
Hmm... i've forgot about that, lol. Probably because i thought at the time that someone with over 16 mil of shares to sell would wait for the PIII results, especially since they (Gen Ilac) have a partnership with Jaguar, so they should know better about the upcoming results.
Did you read the May 1st filing. That’s why it dropped and rises then drops and rises. As soon as all of that is cleaned up it will move up and keep going up. IMO
Imminent is just a tad longer than a Few Weeks…. If you get my drift LOL LOL LOL
Look at the chart, 1 minute timeframe, regular hours (not AM/PM). Find me another one minute red candle,with a >10-14% drop, in recent days/weeks. Not a drop lasting several minutes, just 1 minute red candle with that big of a move. You won't find one.
Maybe it's nothing, but i've found the move strange.
Are you new? it was a stop loss raid like they have done before.
That instant drop from 0.31 to 0.27 is weird. I wonder why was that... I know it can move like that, but rarely in an instant and only on some news. Did they posted anything new, that the market didn't like it? I can't find any...
What are you expecting with 'imminent'? what kind of movement do you forecast? I think the stock is underperforming
Imminent...any day now
I am wondering the same thing and holding
Followers
|
137
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
6957
|
Created
|
12/01/15
|
Type
|
Free
|
Moderators crudeoil24 SmellMyFinger |
Jaguar Health, Inc. $JAGX
Bringing Plant-based Medicines to Life™
Pharmaceutical Manufacturing
San Francisco, California
Jaguar Health’s organizational framework is designed to enable our product pipeline to reach the world’s interconnected marketplace, allowing for development and commercialization opportunities worldwide.
Products:
Mytesi Crofelemer 125mg delayed release tablets
Mytesi is FDA-approved for symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy
Mytesi has a novel mechanism of action that modulates chloride secretion in the gastrointestinal tract, reducing excessive chloride and accompanying water flow and relieving watery diarrhea.
Mytesi is not indicated for the treatment of infectious diarrhea. In clinical studies, the most common adverse reactions occurring at a rate greater than placebo were upper respiratory tract infection (6%), bronchitis (4%), cough (4%), flatulence (3%), and increased bilirubin (3%).
Canalevia-CA1 Crofelemer delayed release tablets
Distributors listed:
https://www.canalevia.com/distributor-information
CANALEVIA-CA1 is conditionally approved for the treatment of chemotherapy-induced diarrhea (CID) in dogs.
Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-552.
CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use this product other than as directed in the labeling.
Pipeline: https://jaguar.health/pipeline/
About the Jaguar Health Family of Companies
Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, and bowel incontinence.
Jaguar Health https://jaguar.health/
Napo Pharmaceuticals https://napopharma.com/
Napo Therapeutics https://napotherapeutics.com/en/
https://www.magdalenabiosciences.com/
Magdalena is a joint venture formed by Jaguar Health and Filament Health. The company holds an exclusive license to Jaguar's proprietary library of approximately 2,300 highly characterized medicinal plants and 3,500 plant extracts for designated therapeutic indications.
Visit Jaguar on LinkedIn:
https://www.linkedin.com/company/jaguar-health/
Visit Jaguar on Instagram: https://www.instagram.com/jaguarhealthcommunity/
Visit Jaguar on X: https://twitter.com/Jaguar_Health
Phone: 415-371-8300
Contact: hello@jaguar.health
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |